Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_759_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
30.08.2026
Размер:
47 Мб
Скачать
4 Nutrition fortheSurgical Patient
35
tion was 18.8% and 7.9%, respectively, in gyne­cological cancer patients during chemotherapy [49].
Radiation therapy is an important adjuvant in pelvic malignancy but one with signicant nutri­tional morbidity. Up to 90% of patients develop a permanent change in their bowel habits after radiation [2]. Intestinal inammation, oxidative stress, tissue damage, and edema lead to pain and functional changes that restrict dietary intake. Functional short bowel syndrome as a cause of protein-calorie malnutrition and micronutrient deciencies is seen in chronic radiation enteritis [53]. Prior to starting pelvic radiation, up to 32% of patients have lost >5% of body weight sug­gesting high risk for malnutrition [36]. In the case of locally advanced rectal cancer requiring neoadjuvant therapy and proctectomy, neoadju­vant therapy contributes to preoperative malnu­trition. A retrospective study of 49 patients with locally advanced rectal cancer in Japan identied malnutrition in 29% of patients at the time of sur­gery following chemoradiation [56].
Perioperative Nutrition andtheGut Microbiome
Particularly for cancer patients, the perioperative course of care has become increasingly pro­tracted and complex with rounds of multimodal­ity therapy. Patients undergoing colorectal resections endure periods of prolonged fasting and mechanical bowel preparation in the weeks before surgery, followed by IV and enteral antibi­otics. While it decreases overall rates of surgical site infections, this course of events has been demonstrated to cause a profound and durable dysbiosis of the colonic microbiome [30]. Surgically induced dysbiosis is exacerbated by preexisting malnutrition [18]. Preoperative diet and the presence of dysbiosis are both mechanis­tically linked to complications such as anasto­motic leak and surgical site infection [50]. Recent translational work suggests that the immune tol­erance induced by diet-induced dysbiosis may permit the recurrence of gastrointestinal cancer [5, 55]. Cutaneous oncologists are leading the
way in reducing antibiotic exposure in cancer patients out of concern for the negative impact of dysbiosis on cancer outcomes [7]. Multiple fecal microbial biomarkers are candidates for a tar­geted preoperative nutritional intervention designed to mitigate specic downstream effects of poor caloric intake [27]. Further translational work is necessary to determine whether the above ndings apply to gastrointestinal and genitouri­nary pelvic surgery.
Potential Solutions: Evidence forMitigation ofPerioperative Malnutrition
Preoperative nutritional counseling in high-risk populations has been demonstrated to improve surgical outcomes in pelvic surgery patients. Generally, nutritional counseling has been employed in the trial setting as part of a preopera­tive bundle or pathway, so while its effect has not been isolated, strong evidence from randomized trials of bundles containing it supports its use [19]. Such sessions are generally performed by a multidisciplinary team of physicians and dieti­cians in the preoperative clinic.
Oral protein-calorie supplementation in the preoperative setting has demonstrated mixed results. Nonselective supplementation for the most part has not demonstrated a benet on post­operative outcomes. However, in patients preop­eratively identied as malnourished, supplementation with 250 mL daily protein­dense shakes reduced rates of surgical site infec­tion compared to dietary counseling alone in a randomized controlled trial [6]. Protein-dense oral nutritional supplementation during postop­erative chemotherapy decreased malnutrition observed in patients after cytoreductive surgery for ovarian cancer [46]. The effects of specialized immunonutrition supplements are mixed based on recent meta-analyses, and no conclusive rec­ommendations can be made at this time. Preoperative probiotics, mostly cultures of Lactobacillus and Bidobacterium, have shown promise in randomized trials in preventing surgi­cal site infection and reducing length of stay [9].
36
R. A. Jacobson et al.
An extensive and well-written review recently summarized available data on preoperative nutri­tional optimization for the cancer patient [5].
Postoperative patients, as a rule, benet from feeding the gut as soon as safely feasible and par­enteral nutrition used only when enteral nutrition is expected to be delayed for long periods. A recent trial randomized 87 patients with nasogas­tric tubes and continuous parenteral nutrition after pelvic exenteration to early trophic feeding versus standard of care suction. The results dem­onstrated that the incidence of postoperative ileus was signicantly lower in participants who were enterally fed. Furthermore, regression analysis showed that the longer patients were restricted from an oral diet after surgery, the greater the time was to rst bowel movement and the greater the postoperative complication rates [25]. In 2013, Roth etal. conducted a clinical trial with patients undergoing radical cystectomy/urinary detour procedures comparing two groups: rst group had parenteral nutrition and oral supple­ments during the rst ve postoperative days and the other had only oral nutritional supplements. The rst cohort was associated with more com­plications in general and infectious complica­tions, adding to the wealth of data that supports parenteral nutrition only being used in cases of expected prolonged inadequate enteral nutrition [48]. There are occasions when the timing of sur­gery cannot be delayed, however. In instances of surgery on patients with or at high risk for malnu­trition, consideration of early initiation of paren­teral nutritional is justied. In a recent study of patients undergoing abdominal surgery, initiation of TPN at day 3 reduced infectious complications compared to initiation on day 8 [57].

Conclusions

Malnutrition is a signicant modiable risk fac­tor in pelvic surgery across specialties. Patients and providers stand to gain from low-cost periop­erative interventions that could improve surgical outcomes. Current data support the following practices: (1) Malnutrition needs to be recog­nized and measured in all patients prior to pelvic
surgery using validated risk stratication tools. (2) If indicated, nutritional and physical preha­bilitation should be implemented before surgery in a way that ts patients’ means and abilities. (3) All patients should initiate enteral nutrition as early as possible in the postoperative period, with protein-calorie supplementation where needed. (4) Parenteral nutrition should be promptly initi­ated only in patients unable to receive adequate energy through the gut. Further study is required to use preoperative nutritional intervention, per­haps with prebiotics, to build resilience in the gut microbiome and prevent its attendant complica­tions. Barriers to improving perioperative nutri­tion practices stem principally from poor transfer of information from the appropriate providers to patients during the perioperative period. Buy-in to dietary education from patients and multidisci­plinary teams of providers is essential to improve surgical outcomes in the future.

References

1. Anthony PS. Nutrition screening tools for hospital­ized patients. Nutr Clin Pract. 2008;23(4):373–82.
https://doi.org/10.1177/0884533608321130.
2. Araujo IK, Munoz-Guglielmetti D, Molla M. Radiation-induced damage in the lower gas­trointestinal tract: clinical presentation, diagnos­tic tests and treatment options. Best Pract Res Clin Gastroenterol. 2020;48-49:101707. https://doi.
org/10.1016/j.bpg.2020.101707.
3. Asteria CR, Gagliardi G, Pucciarelli S, Romano G, Infantino A, La Torre F, Tonelli F, Martin F, Pulica C, Ripetti V, Diana G, Amicucci G, Carlini M, Sommariva A, Vinciguerra G, Poddie DB, Amato A, Bassi R, Galleano R, Veronese E, Mancini S, Pescio G, Occelli GL, Bracchitta S, Castagnola M, Pontillo T, Cimmino G, Prati U, Vincenti R.Anastomotic leaks after anterior resection for mid and low rectal cancer: survey of the Italian Society of Colorectal Surgery. Tech Coloproctol. 2008;12(2):103–10. https://doi.
org/10.1007/s10151- 008- 0407- 9.
4. Bernstein LH, Leukhardt-Faireld CJ, Pleban W, Rudolph R.Usefulness of data on albumin and pre­albumin concentrations in determining effectiveness of nutritional support. Clin Chem. 1989;35(2):271–4.
5. Brajcich BC, Stigall K, Walsh DS, Varghese TK, Barber AE, Kralovich KA, Wescott AB, Pockaj BA, Ko CY, Laronga C. Preoperative nutritional opti­mization of the oncology patient: a scoping review. J Am Coll Surg. 2022;234(3):384–94. https://doi.
org/10.1097/XCS.0000000000000055.
4 Nutrition fortheSurgical Patient
37
6. Burden ST, Gibson DJ, Lal S, Hill J, Pilling M, Soop M, Ramesh A, Todd C.Pre-operative oral nutritional supplementation with dietary advice versus dietary advice alone in weight-losing patients with colorec­tal cancer: single-blind randomized controlled trial. J Cachexia Sarcopenia Muscle. 2017;8(3):437–46.
https://doi.org/10.1002/jcsm.12170.
7. Cass RGW, Meng X, Sahasrabhojane P, Bassett RL, Shelburne S, Chang HY, Somaiya K, Mungovan K, Fisher SB, Lucci A, Lee JE, Ross MI, Gershenwald JE, Duncan S, Ajami NJ, Roland CL, Wargo JA, Keung EZ-Y. Evaluating the impact of perioperative antibiotic prophylaxis on the microbiome in patients with cutaneous malignancy. Abstract presented at JCO.J Clin Oncol. 2022;40(16 suppl):TPS9602.
8. Cederholm T, Jensen GL, Correia M, Gonzalez MC, Fukushima R, Higashiguchi T, Baptista G, Barazzoni R, Blaauw R, Coats AJS, Crivelli AN, Evans DC, Gramlich L, Fuchs-Tarlovsky V, Keller H, Llido L, Malone A, Mogensen KM, Morley JE, Muscaritoli M, Nyulasi I, Pirlich M, Pisprasert V, de van der Schueren MAE, Siltharm S, Singer P, Tappenden K, Velasco N, Waitzberg D, Yamwong P, Yu J, Van Gossum A, Compher C, Glim Core Leadership Committee GWG. GLIM criteria for the diagnosis of malnutrition—a consensus report from the global clinical nutrition community. J Cachexia Sarcopenia Muscle. 2019;10(1):207–17. https://doi.org/10.1002/
jcsm.12383.
9. Chowdhury AH, Adiamah A, Kushairi A, Varadhan KK, Krznaric Z, Kulkarni AD, Neal KR, Lobo DN. Perioperative probiotics or Synbiotics in adults undergoing elective abdominal surgery: a systematic review and meta-analysis of randomized controlled trials. Ann Surg. 2020;271(6):1036–47. https://doi.
org/10.1097/SLA.0000000000003581.
10. Coda A, Bossotti M, Ferri F, Mattio R, Ramellini G, Poma A, Quaglino F, Filippa C, Bona A. Incisional hernia and fascial defect following laparoscopic surgery. Surg Laparosc Endosc Percutan Tech. 2000;10(1):34–8.
11. Curran T. Perioperative nutritional consider­ations in colon and Rectal surgery. Clin Colon Rectal Surg. 2023;36(3):192–7. https://doi.
org/10.1055/s- 0043- 1761152.
12. Davis CJ, Sowa D, Keim KS, Kinnare K, Peterson S. The use of prealbumin and C-reactive protein for monitoring nutrition sup­port in adult patients receiving enteral nutri­tion in an urban medical center. JPEN J Parenter Enteral Nutr. 2012;36(2):197–204. https://doi.
org/10.1177/0148607111413896.
13. de Oliveira AL, Boroni Moreira AP, Pereira Netto M, Goncalves Leite IC.A cross-sectional study of nutri­tional status, diet, and dietary restrictions among per­sons with an ileostomy or colostomy. Ostomy Wound Manage. 2018;64(5):18–29.
14. Detsky AS, McLaughlin JR, Baker JP, Johnston N, Whittaker S, Mendelson RA, Jeejeebhoy KN. What is subjective global assess-
ment of nutritional status? JPEN J Parenter Enteral Nutr. 1987;11(1):8–13. https://doi.
org/10.1177/014860718701100108.
15. Duerksen DR, Laporte M, Jeejeebhoy K.Evaluation of nutrition status using the subjective global assess­ment: malnutrition, cachexia, and sarcopenia. Nutr Clin Pract. 2021;36(5):942–56. https://doi.
org/10.1002/ncp.10613.
16. Fazzini B, Markl T, Costas C, Blobner M, Schaller SJ, Prowle J, Puthucheary Z, Wackerhage H. The rate and assessment of muscle wasting during criti­cal illness: a systematic review and meta-analysis. Crit Care. 2023;27(1):2. https://doi.org/10.1186/
s13054- 022- 04253- 0.
17. Fleck A.Clinical and nutritional aspects of changes in acute-phase proteins during inammation. Proc Nutr Soc. 1989;48(3):347–54. https://doi.org/10.1079/
pns19890050.
18. Gaines S, van Praagh JB, Williamson AJ, Jacobson RA, Hyoju S, Zaborin A, Mao J, Koo HY, Alpert L, Bissonnette M, Weichselbaum R, Gilbert J, Chang E, Hyman N, Zaborina O, Shogan BD, Alverdy JC.Western diet promotes intestinal colonization by Collagenolytic microbes and promotes tumor for­mation after colorectal surgery. Gastroenterology. 2020;158(4):958–970 e952. https://doi.org/10.1053/j.
gastro.2019.10.020.
19. Gillis C, Buhler K, Bresee L, Carli F, Gramlich L, Culos-Reed N, Sajobi TT, Fenton TR. Effects of nutritional prehabilitation, with and without exer­cise, on outcomes of patients who undergo colorec­tal surgery: a systematic review and meta-analysis. Gastroenterology. 2018;155(2):391–410 e394. https://
doi.org/10.1053/j.gastro.2018.05.012.
20. Grace E, Shaw C, Whelan K, Andreyev HJ.Review article: small intestinal bacterial overgrowth—prev­alence, clinical features, current and developing diagnostic tests, and treatment. Aliment Pharmacol Ther. 2013;38(7):674–88. https://doi.org/10.1111/
apt.12456.
21. Guigoz Y, Vellas B.The mini nutritional assessment (MNA) for grading the nutritional state of elderly patients: presentation of the MNA, history and vali­dation. Nestle Nutr Workshop Ser Clin Perform Programme. 1999;1:3–11.; discussion 11–12. https://
doi.org/10.1159/000062967.
22. Guigoz Y, Vellas B. Nutritional assessment in older adults : MNA(R) 25 years of a screening tool and a reference standard for care and research; what next? J Nutr Health Aging. 2021;25(4):528–83. https://doi.
org/10.1007/s12603- 021- 1601- y.
23. Heper Y, Akalin EH, Mistik R, Akgoz S, Tore O, Goral G, Oral B, Budak F, Helvaci S. Evaluation of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha, and interleukin-10 levels as diagnostic and prognostic parameters in patients with community- acquired sepsis, severe sep­sis, and septic shock. Eur J Clin Microbiol Infect Dis. 2006;25(8):481–91. https://doi.org/10.1007/
s10096- 006- 0168- 1.
38
R. A. Jacobson et al.
24. Heyland DK, Dhaliwal R, Jiang X, Day AG. Identifying critically ill patients who benet the most from nutrition therapy: the development and initial validation of a novel risk assessment tool. Crit Care. 2011;15(6):R268. https://doi.org/10.1186/
cc10546.
25. Hogan S, Reece L, Solomon M, Rangan A, Carey S. Early enteral feeding is benecial for patients after pelvic exenteration surgery: a randomized controlled trial. JPEN J Parenter Enteral Nutr. 2022;46(2):411–21. https://doi.org/10.1002/
jpen.2120.
26. Jones KI, Doleman B, Scott S, Lund JN, Williams JP. Simple psoas cross-sectional area measurement is a quick and easy method to assess sarcopenia and predicts major surgical complications. Color Dis. 2015;17(1):O20–6. https://doi.org/10.1111/
codi.12805.
27. Jonkers DM. Microbial perturbations and modula­tion in conditions associated with malnutrition and malabsorption. Best Pract Res Clin Gastroenterol. 2016;30(2):161–72. https://doi.org/10.1016/j.
bpg.2016.02.006.
28. Kathiresan AS, Brookeld KF, Schuman SI, Lucci JA 3rd. Malnutrition as a predictor of poor postop­erative outcomes in gynecologic cancer patients. Arch Gynecol Obstet. 2011;284(2):445–51. https://doi.
org/10.1007/s00404- 010- 1659- y.
29. Kondrup J. Nutritional-risk scoring systems in the intensive care unit. Curr Opin Clin Nutr Metab Care. 2014;17(2):177–82. https://doi.org/10.1097/
MCO.0000000000000041.
30. Krezalek MA, Alverdy JC.The role of the microbi­ota in surgical recovery. Curr Opin Clin Nutr Metab Care. 2016;19(5):347–52. https://doi.org/10.1097/
MCO.0000000000000299.
31. Lanctin DP, Merced-Nieves F, Mallett RM, Arensberg MB, Guenter P, Sulo S, Platts-Mills TF.Prevalence and economic Burden of malnutrition diagnosis among patients presenting to United States Emergency Departments. Acad Emerg Med. 2021;28(3):325–35.
https://doi.org/10.1111/acem.13887.
32. Lee DU, Fan GH, Hastie DJ, Addonizio EA, Suh J, Prakasam VN, Karagozian R. The clinical impact of malnutrition on the postoperative outcomes of patients undergoing colorectal resection sur­gery for colon or rectal cancer: propensity score matched analysis of 2011–2017 US hospitals. Surg Oncol. 2021;38:101587. https://doi.org/10.1016/j.
suronc.2021.101587.
33. Lin J, Peng J, Qdaisat A, Li L, Chen G, Lu Z, Wu X, Gao Y, Zeng Z, Ding P, Pan Z. Severe weight loss during preoperative chemoradiotherapy com­promises survival outcome for patients with locally advanced rectal cancer. J Cancer Res Clin Oncol. 2016;142(12):2551–60. https://doi.org/10.1007/
s00432- 016- 2225- 1.
34. Makela JT, Kiviniemi H, Juvonen T, Laitinen S. Factors inuencing wound dehiscence after mid-
line laparotomy. Am J Surg. 1995;170(4):387–90.
https://doi.org/10.1016/s0002- 9610(99)80309- 2.
35. McClave SA, DiBaise JK, Mullin GE, Martindale RG. ACG clinical guideline: nutrition therapy in the adult hospitalized patient. Am J Gastroenterol. 2016;111(3):315–34.; quiz 335. https://doi.
org/10.1038/ajg.2016.28.
36. McGough C, Baldwin C, Frost G, Andreyev HJ.Role of nutritional intervention in patients treated with radiotherapy for pelvic malignancy. Br J Cancer. 2004;90(12):2278–87. https://doi.org/10.1038/
sj.bjc.6601868.
37. McKenna NP, Bews KA, Al-Refaie WB, Colibaseanu DT, Pemberton JH, Cima RR, Habermann EB. Assessing malnutrition before major oncologic surgery: one size does not t all. J Am Coll Surg. 2020;230(4):451–60. https://doi.org/10.1016/j.
jamcollsurg.2019.12.034.
38. Moraes JT, Melo AFF, Araujo C, Faria R, Ferreira NR, Belo VS. Anthropometric and dietetic evalua­tion of people with ileostomies. Arq Gastroenterol. 2019;56(1):34–40. https://doi.org/10.1590/
S0004- 2803.201900000- 07.
39. Nakayama M, Yoshimatsu K, Yokomizo H, Yano Y, Okayama S, Satake M, Matsumoto A, Fujimoto T, Usui T, Yamaguchi K, Shiozawa S, Shimakawa T, Katsube T, Naritaka Y. Incidence and risk factors for incisional hernia after open surgery for colorectal can­cer. Hepato-Gastroenterology. 2014;61(133):1220–3.
40. Ornaghi PI, Afferi L, Antonelli A, Cerruto MA, Odorizzi K, Gozzo A, Mordasini L, Mattei A, Baumeister P, Cornelius J, Tafuri A, Moschini M. The impact of preoperative nutritional status on post-surgical complication and mortality rates in patients undergoing radical cystectomy for bladder cancer: a systematic review of the literature. World J Urol. 2021;39(4):1045–81. https://doi.org/10.1007/
s00345- 020- 03291- z.
41. Ottery FD. Bidirectional interplay of nutrition and chemotherapy. Nestle Nutr Workshop Ser Clin Perform Programme. 2000;4:183–202.; discussion 203–186. https://doi.org/10.1159/000061815.
42. Paur I, Smedshaug GB, Haugum B, Bye A, Eliassen E, Flottorp TL, Juul HJ, Mowe M, Nakken T, Ore S, Sirevag GK, Sygnestveit K, Thoresen L, Aasen EB, Totland TH, Krogh HW. The Norwegian Directorate of Health recommends malnutri­tion screening tool (MST) for all adults. Clin Nutr ESPEN. 2022;52:28–31. https://doi.org/10.1016/j.
clnesp.2022.09.029.
43. Portuondo JI, Probstfeld L, Massarweh NN, Le L, Wei Q, Chai CY, Taylor J, Awad SS, Tran Cao HS. Malnutrition in elective surgery: how tra­ditional markers might be failing surgeons and patients. Surgery. 2020;168(6):1144–51. https://doi.
org/10.1016/j.surg.2020.08.012.
44. Pressoir M, Desné S, Berchery D, Rossignol G, Poiree B, Meslier M, Traversier S, Vittot M, Simon M, Gekiere JP, Meuric J, Serot F, Falewee MN, Rodrigues I, Senesse P, Vasson MP, Chelle F, Maget B, Antoun
4 Nutrition fortheSurgical Patient
39
S, Bachmann P.Prevalence, risk factors and clinical implications of malnutrition in French comprehensive cancer Centres. Br J Cancer. 2010;102(6):966–71.
https://doi.org/10.1038/sj.bjc.6605578.
45. Puthucheary ZA, McNelly AS, Rawal J, Connolly B, Sidhu PS, Rowlerson A, Moxham J, Harridge SD, Hart N, Montgomery HE. Rectus Femoris cross­sectional area and muscle layer thickness: compara­tive markers of muscle wasting and weakness. Am J Respir Crit Care Med. 2017;195(1):136–8. https://
doi.org/10.1164/rccm.201604- 0875LE.
46. Qin N, Jiang G, Zhang X, Sun D, Liu M.The effect of nutrition intervention with oral nutritional supple­ments on ovarian cancer patients undergoing che­motherapy. Front Nutr. 2021;8:685967. https://doi.
org/10.3389/fnut.2021.685967.
47. Quigley EMM, Murray JA, Pimentel M. AGA clinical practice update on small intestinal bacte­rial overgrowth: expert review. Gastroenterology. 2020;159(4):1526–32. https://doi.org/10.1053/j.
gastro.2020.06.090.
48. Roth B, Birkhauser FD, Zehnder P, Thalmann GN, Huwyler M, Burkhard FC, Studer UE. Parenteral nutrition does not improve postoperative recovery from radical cystectomy: results of a prospective ran­domised trial. Eur Urol. 2013;63(3):475–82. https://
doi.org/10.1016/j.eururo.2012.05.052.
49. Sanguanwongthong K, Suprasert P. Prevalence of malnourishment and predictive factors associated with the nutritional status of gynecologic cancer patients undergoing chemotherapy: a cross-sectional analysis. Obstet Gynecol Sci. 2022;65(3):234–43.
https://doi.org/10.5468/ogs.21298.
50. Shogan BD, Belogortseva N, Luong PM, Zaborin A, Lax S, Bethel C, Ward M, Muldoon JP, Singer M, An G, Umanskiy K, Konda V, Shakhsheer B, Luo J, Klabbers R, Hancock LE, Gilbert J, Zaborina O, Alverdy JC. Collagen degradation and MMP9 activation by enterococcus faecalis contribute to intestinal anasto­motic leak. Sci Transl Med. 2015;7(286):286ra268.
https://doi.org/10.1126/scitranslmed.3010658.
51. Soloff MA, Vargas MV, Wei C, Ohnona A, Tyan P, Gu A, Georgakopoulos B, Thomas CA, Quan T, Barishansky S, Moawad G.Malnutrition is associated with poor postoperative outcomes following laparo­scopic hysterectomy. JSLS. 2021;25(1):e2020.00084.
https://doi.org/10.4293/JSLS.2020.00084.
52. Thurnham DI. Interactions between nutrition and immune function: using inammation biomark­ers to interpret micronutrient status. Proc Nutr Soc. 2014;73(1):1–8. https://doi.org/10.1017/
S0029665113003662.
53. Webb GJ, Brooke R, De Silva AN. Chronic radiation enteritis and malnutrition. J Dig Dis. 2013;14(7):350–7. https://doi.
org/10.1111/1751- 2980.12061.
54. White JV, Guenter P, Jensen G, Malone A, Schoeld M. Consensus statement: academy of nutrition and dietetics and American Society for Parenteral and Enteral Nutrition. J Parenter Enter Nutr. 2012;36(3):275–83. https://doi.
org/10.1177/0148607112440285.
55. Williamson AJ, Jacobson R, van Praagh JB, Gaines S, Koo HY, Lee B, Chan WC, Weichselbaum R, Alverdy JC, Zaborina O, Shogan BD. Enterococcus faecalis promotes a migratory and invasive phenotype in colon cancer cells. Neoplasia. 2022;27:100787. https://doi.
org/10.1016/j.neo.2022.100787.
56. Yamano T, Yoshimura M, Kobayashi M, Beppu N, Hamanaka M, Babaya A, Tsukamoto K, Noda M, Matsubara N, Tomita N. Malnutrition in rectal can­cer patients receiving preoperative chemoradio­therapy is common and associated with treatment tolerability and anastomotic leakage. Int J Color Dis. 2016;31(4):877–84. https://doi.org/10.1007/
s00384- 016- 2507- 8.
57. Zhu Z, Gao Z, Li K.Supplemental parenteral nutri­tion in patients undergoing abdominal surgery. JAMA Surg. 2022;157(10):966–7. https://doi.org/10.1001/
jamasurg.2022.2654.
Uterine Surgery forInfertility
JensenReckhow andZaraqKhan
5
Bleeding andNeed forHysterectomy

Background

Bleeding is one of the most signicant risks of uterine surgery, as the uterus has a rich blood supply and uterine-sparing surgeries are often complex. Blood loss is of particular concern in more complex surgeries such as myomectomy, adenomyomectomy, and excision of deep inl­trating endometriosis, and excessive blood loss increases the risk of surgical site infection, trans­fusion, and reoperation [1]. Furthermore, signi­cant blood loss at the time of myomectomy increases the risk for hysterectomy [25]. While there is currently no data on the risk of hysterec­tomy at the time of adenomyomectomy, this is likely to be a considerable risk as these proce­dures are technically challenging.
Bleeding is also the most common complica­tion after transvaginal ultrasound-guided oocyte retrieval—the most frequently performed proce­dure by reproductive endocrinologists.
J. Reckhow Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN, USA e-mail: reckhow.jensen@mayo.edu
Z. Khan (*) Division Chair for Reproductive Endocrinology and Infertility, Mayo Clinic, Rochester, MN, USA e-mail: khan.zaraq@mayo.edu

Prevention

Medical optimization prior to surgery reduces complications. Preoperative anemia should be identied; pretreatment with oral or intravenous iron supplementation may reduce transfusion risk for patients undergoing procedures with a high anticipated blood loss [1]. Preoperative treatment with gonadotropin releasing hormone (GnRH) analogs should be considered in patients with leiomyomas or adenomyosis, as treatment can reduce uterine size and thereby help decrease intraoperative blood loss [6, 7]. Cumulative sur­gical complication risk is lower with laparoscopic myomectomy than open myomectomy and is notably associated with a vefold reduction in blood transfusion risk [1, 8]. While the risk of any complication is currently lower with laparo­scopic approach as compared to robotic approach, this difference is likely to be mitigated as robotic training becomes more widespread [9].
Minimizing intraoperative blood loss improves visualization and reduces risk of other surgical complications. When performing myo­mectomy through any approach, vasopressin injected into the cervix as well as the broids themselves helps reduce blood ow to the surgi­cal eld [1012]. Transient occlusion of the uterine arteries (TOUA) and use of a uterine tourniquet have been shown to decrease blood loss during adenomyomectomy (Figs.5.1 and
5.2) [13]. Preoperative administration of miso-
© The Author(s), under exclusive license to Springer Nature Switzerland AG 2025 M. Hoffman et al. (eds.), Major Complications of Female Pelvic Surgery,
https://doi.org/10.1007/978-3-031-66772-5_5
43
44
Uterus
Ut
Uterus
niquet
J. Reckhow and Z. Khan
erine artery
Leiomyoma
Fig. 5.1 A Bulldog clamp may be used to temporarily occlude the uterine vessels, decreasing the pulse pressure of blood ow to the uterus
Broad ligament
Uterine artery
Tour
Fig. 5.2 A Penrose drain may be placed circumferentially around the cervix, passing it through the broad ligament on either side, to temporarily occlude the uterine vessels during uterine surgery
ab
cd
5 Uterine Surgery forInfertility
45
Fig. 5.3 (a–d) During transvaginal oocyte retrieval, sig- nicant hemorrhage can occur if the iliac vessels are mis­takenly entered. (a) and (b) (without and with color doppler ow) show ovarian follicles in close proximity to the iliac vessels. In this plane, the vessels are readily dis­tinguished from the follicles by shape. (c) and (d) (with-
prostol reduces blood ow to the uterus and may
out and with color doppler ow) show the same follicles and the iliac vessels in cross section. In this view, the ves­sels may be mistaken for follicles. It is essential to note the difference in echogenicity between the follicles and the vessels, as this may be the main distinguishing feature between the two

Recognition

decrease blood loss for any uterine surgery [6]. Prophylactic administration of tranexamic acid is also associated with decreased intraoperative blood loss [13]. Intraoperative blood salvage is not recommended for routine use but may decrease the risk of blood transfusion in appro­priately selected patients with a high burden of disease and when a prolonged, complex surgery is anticipated [14, 15].
Ultrasound guidance during oocyte retrieval allows the operator to stay clear of the iliac ves­sels upon which a stimulated ovary typically rests. In a certain plane, these large iliac vessels can be confused with a follicle. Closely watching for vessel movement with pulsation and turning the ultrasound probe to change the plane of view allows for differentiation of a large vessel from a stimulated follicle (Fig.5.3a–d).
A discussion of anticipated blood loss should take place prior to surgery with the full multidis­ciplinary surgical team so that a plan may be devised for intraoperative blood loss monitoring and resuscitation as needed. In hysteroscopic procedures, excess blood loss is easily recog­nized as the visual eld is rapidly obscured by high-volume bleeds. In complex open or mini­mally invasive surgeries, intraoperative blood loss may be more insidious, and strict monitoring is needed. The surgeon should monitor for signs of uterine atony and evolving coagulopathy, which may develop in response to as well as pre­cipitate further blood loss. Frequent closed-loop communication between the surgeon, nursing, and anesthesiology staff allows for timely response to blood loss with resuscitation with
46
J. Reckhow and Z. Khan
intravenous hydration, blood products, and vaso­pressor support to maintain hemodynamic stabil­ity. In these cases, it is essential to perform serial assessments of complete blood counts as well as coagulation proles, as signicant blood loss may precipitate coagulopathy or even dissemi­nated intravascular coagulation (DIC), requiring judicious repletion of clotting factors [16, 17].
Vascular injuries should be repaired by an experi­enced surgeon. Minor low-volume oozing may be managed with direct pressure, cauterization of the vessel with monopolar or bipolar energy, suturing of the vessel, or application of hemo­static agents. Mechanical hemostatic agents come in a variety of forms (cloth, powder, foam, or sponge) and tend to be less costly than bio­logic agents. These agents work by establishing a scaffold for platelet adherence and activation [18,

Management

19]. Biologic hemostatic agents act directly on
the common pathway of the coagulation cascade In the event of hemorrhage, immediate direct pressure tamponade affords the surgeon time to plan management. If the source of the hemor­rhage is visualized, the offending vessel may be tamponaded directly. If unable to identify the source of hemorrhage, temporary tamponade of the internal iliac vessels or even the common iliac vessels can afford the surgeon time to clear the surgical eld to identify the source of bleeding.
Table 5.1 Hemostatic Agents
Agent Mechanism of action Advantages Limitations Mechanical agents Oxidative
regenerating cellulose
Microbrillar collagen
Hydrocolloid gelatin matrix
Polysaccharide spheres
Scaffold for platelet aggregation Establishes acidic environment that induces local vasoconstriction Bactericidal
Scaffold for platelet adherence and activation
Direct pressure from weight of the agent (absorb 35–45 times their weight in uid)
Absorbs water content from blood, increasing concentration of platelets and proteins to accelerate intrinsic clotting cascade
to form a brin clot. These agents may require
thawing or reconstitution by a trained operator
prior to use [18, 20]. Table5.1 outlines common
hemostatic agents used in gynecologic surgery
[18].
Most bleeding after oocyte retrieval is self­limited, and typically close observation with serial hemoglobin assessment is the primary management strategy in this scenario.
Pliable so can be passed through laparoscopic trocars Less expensive
Less expensive Comes in multiple forms (powder, sheet)
May be used with biologic agents Less expensive
Powder form allows for diffuse application Not immunogenic Rapidly absorbed
Acidic environment inactivates biologic hemostatic agents, so this must be used alone or with other mechanical agents only Delayed absorption; can be mistaken for abscess or malignancy on imaging
Can be sticky and difcult to handle Increased risk of abscess formation Bovine-derived and may be immunogenic
Porcine-derived and may be immunogenic Increased risk of abscess formation
Large doses (>50g) may precipitate hyperglycemia
(continued)
5 Uterine Surgery forInfertility
Table 5.1 (continued)
Agent Mechanism of action Advantages Limitations Biologic agents Thrombin Activates factors V, VIII, and XI
Thrombin + gelatin
Fibrin Stabilizes clot by forming
Promotes platelet activation Converts brinogen to brin
Combined effects of thrombin and gelatin agents
insoluble brin mesh scaffold for platelet organization
Effect is immediate Black box warning against
repeated use of bovine-derived thrombin as it is highly immunogenic May transmit blood-borne disease
Effect is immediate Increased risk of small bowel
obstruction (POD#5–9) Gentle irrigation is required to remove excess matrix after application to reduce adhesive disease formation Delayed absorption; can be mistaken for abscess or malignancy on imaging
Effect is immediate Expensive
47
Formation ofIntrauterine Adhesive Disease

Background

The formation of intrauterine scar tissue is a dreaded complication after uterine instrumenta­tion and curettage, particularly after management of rst or second trimester pregnancy loss or retained placenta after delivery [21]. The true prevalence of intrauterine adhesive disease (IUA) and Asherman’s syndrome (IUA formation after instrumentation of a gravid uterus) is unknown, as the condition may be asymptomatic [22]. The risk of scar tissue formation is highest after instrumentation of the postpartum uterus, with most risk occurring between the 2nd and 4th week postpartum (19–27%) [2325] or after rst trimester pregnancy loss (19%) [26]. Intrauterine adhesive disease may also develop after uterine septoplasty, extensive hysteroscopic myomec­tomy, and abdominal myomectomy with entry into the endometrial cavity [27]. Tissue ischemia secondary to uterine artery embolization or pel­vic radiation may also induce intrauterine adhe­sion formation [28].

Prevention

When considering strategies to prevent intrauter­ine adhesion formation, it is important to consider both primary prevention as well as secondary pre­vention after surgical resection of existing adhe­sive disease. Unfortunately, the optimal approach to prevent IUA formation remains unknown [29,
30]. Hysteroscopic tissue resection for pregnancy
loss or retained products of conception may decrease the risk of intrauterine adhesion forma­tion (primary prevention) as compared to tradi­tional blind curettage; however, data in this area remain mixed [31]. Secondary prevention after surgical resection of existing disease can be pro­vided with placement of a solid barrier such as a Foley catheter balloon to prevent adhesion forma­tion within the endometrium, although studies investigating the utility of this have not shown a clear reduction in intrauterine adhesion formation or subsequent pregnancy outcomes [3234]. Limited evidence suggests that semisolid barriers such as hyaluronic acid gels or delayed absorbable adhesion barriers such as carboxymethylcellulose may decrease postoperative IUA formation [35,
36]. The role of hormonal treatments in reducing
IUA formation remains to be determined [37, 38].